Promising updates on coronavirus vaccine: Final analysis finds it 95 percent effective
As the number of coronavirus cases continue to surge across the country, the hunt for a vaccine has taken another big step today. Pfizer and BioNTech say that a final data analysis found their vaccine candidate was more effective in preventing COVID-19 than originally thought, and it also appears to fend off severe disease. The companies now say they plan on applying for an emergency use authorization with the FDA "within days."
promising news from Pfizer and biotech companies say AH, final data analysis of their coronavirus vaccine finds its 95% effective higher than preliminary results indicated. This is really hopeful, right? This is great news. Both Madonna and Pfizer, now at about 95% effectiveness, according to Pfizer. And by on Tech, there were 170 confirmed cases of Cove in 19 among trial volunteers, 162 occurring in the placebo group. Of the 10 severe cases of illness, just one was in the vaccine group. It was well tolerated and consistently effective across different age and racial groups. The company's plan to submit an application for emergency use authorization within days. This is where we remember that the vaccine doesn't save your life. But vaccination does remember that vaccines don't deliver themselves the country now grappling with the logistical challenges of shipping and distribution. It is a large task, but it's a task that we are up for and combating climbing covert infections. Health experts urging continued mask wearing social distancing and skipping large Thanksgiving gatherings were in a absolutely dangerous situation that we have to take with the utmost seriousness. This is not crying wolf. A plea to the public to help save lives. Sarah Doll If NBC News